Attached files

file filename
8-K - FORM 8-K - CRANE CO /DE/d246808d8k.htm
EX-99.1 - EARNINGS PRESS RELEASE - CRANE CO /DE/d246808dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Net Sales:

        

Aerospace & Electronics

   $ 172,216      $ 143,161      $ 505,690      $ 416,105   

Engineered Materials

     53,101        54,904        175,034        167,305   

Merchandising Systems

     98,815        77,199        287,703        221,897   

Fluid Handling

     303,553        255,842        856,660        758,218   

Controls

     31,771        29,608        89,162        80,294   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Net Sales

   $ 659,456      $ 560,714      $ 1,914,249      $ 1,643,819   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Profit (Loss):

        

Aerospace & Electronics

   $ 35,640      $ 25,368      $ 106,839      $ 76,072   

Engineered Materials

     5,919        7,965        25,192        26,677   

Merchandising Systems

     10,845        6,261        22,632        19,340   

Fluid Handling

     40,866        33,197        113,262        93,338   

Controls

     4,619        1,949        11,447        2,900   

Corporate

     (15,773     (11,861     (44,453     (36,864
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Operating Profit

     82,116        62,879        234,919        181,463   

Interest Income

     442        299        1,121        760   

Interest Expense

     (6,474     (6,738     (19,525     (20,121

Miscellaneous – Net

     (73     1,522        3,262     897   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income Before Income Taxes

     76,011        57,962        219,777        162,999   

Provision for Income Taxes

     23,605        16,359        68,456        48,049   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income before allocations to noncontrolling interests

     52,406        41,603        151,321        114,950   

Less: Noncontrolling interest in subsidiaries’ (losses) earnings

     (134     96        (123     168   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to common shareholders

   $ 52,540      $ 41,507      $ 151,444      $ 114,782   
  

 

 

   

 

 

   

 

 

   

 

 

 

Share Data:

        

Earnings per Diluted Share

   $ 0.89      $ 0.70      $ 2.55      $ 1.92   
  

 

 

   

 

 

   

 

 

   

 

 

 

Average Diluted Shares Outstanding

     59,058        59,525        59,330        59,645   

Average Basic Shares Outstanding

     58,048        58,608        58,202        58,710   

Supplemental Data:

        

Cost of Sales

   $ 436,437      $ 373,171      $ 1,257,328      $ 1,087,221   

Selling, General & Administrative

     140,903        124,664        422,002        375,135   

Depreciation and Amortization **

     15,581        14,751        47,208        44,596   

Stock-Based Compensation Expense

     3,858        3,306        11,132        9,650   

 

* Primarily related to the sale of a building and the divestiture of a small product line in the three months ended March 31, 2011.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     September 30,
2011
     December 31,
2010
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 211,183       $ 272,941   

Accounts Receivable, net

     379,764         301,918   

Current Insurance Receivable – Asbestos

     33,000         33,000   

Inventories, net

     363,751         319,077   

Other Current Assets

     70,079         61,725   
  

 

 

    

 

 

 

Total Current Assets

     1,057,777         988,661   

Property, Plant and Equipment, net

     289,667         280,746   

Long-Term Insurance Receivable – Asbestos

     156,810         180,689   

Other Assets

     408,204         446,316   

Goodwill

     821,731         810,285   
  

 

 

    

 

 

 

Total Assets

   $ 2,734,189       $ 2,706,697   
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 752       $ 984   

Accounts Payable

     180,917         157,051   

Current Asbestos Liability

     100,000         100,000   

Accrued Liabilities

     224,746         229,462   

Income Taxes

     32,538         11,057   
  

 

 

    

 

 

 

Total Current Liabilities

     538,953         498,554   

Long-Term Debt

     398,869         398,736   

Long-Term Deferred Tax Liability

     47,344         48,852   

Long-Term Asbestos Liability

     536,554         619,666   

Other Liabilities

     131,041         147,859   

Total Equity

     1,081,428         993,030   
  

 

 

    

 

 

 

Total Liabilities and Equity

   $ 2,734,189       $ 2,706,697   
  

 

 

    

 

 

 


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Operating Activities:

        

Net income attributable to common shareholders

   $ 52,540      $ 41,507      $ 151,444      $ 114,782   

Noncontrolling interest in subsidiaries’ (losses) earnings

     (134     96        (123     168   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income before allocations to noncontrolling interests

     52,406        41,603        151,321        114,950   

Gain on divestiture

     —          (1,015     (4,258     (1,015

Depreciation and amortization

     15,581        14,751        47,208        44,596   

Stock-based compensation expense

     3,858        3,306        11,132        9,650   

Defined benefit plans and postretirement expense

     1,811        3,077        5,403        9,227   

Deferred income taxes

     8,219        17,693        21,739        30,913   

Cash provided by (used for) operating working capital

     8,479        (35,721     (76,912     (56,367

Defined benefit plans and postretirement contributions

     (6,696     (33,717 ) *      (17,054 )       (40,006 ) * 

Environmental payments, net of reimbursements

     (2,601     (4,588     (8,735     (10,905

Other

     (7,654     6,177        (5,617     1,912   
  

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal

     73,403        11,566        124,227        102,955   

Asbestos related payments, net of insurance recoveries

     (23,612     (16,167     (59,233     (43,652
  

 

 

   

 

 

   

 

 

   

 

 

 

Total provided by (used for) operating activities

     49,791        (4,601     64,994        59,303   
  

 

 

   

 

 

   

 

 

   

 

 

 

Investing Activities:

        

Capital expenditures

     (9,421     (5,199     (27,703     (13,589

Proceeds from disposition of capital assets

     190        143        4,720        185   

Payment for acquisition, net of cash acquired

     (35,594     —          (35,594     (51,167

Proceeds from divestiture

     —          4,615        1,000        4,615   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total used for investing activities

     (44,825     (441     (57,577     (59,956
  

 

 

   

 

 

   

 

 

   

 

 

 

Financing Activities:

        

Dividends paid

     (15,098     (13,453     (41,957     (37,011

Reacquisition of shares on open market

     —          (19,999     (49,999     (29,989

Stock options exercised – net of shares reacquired

     2,913        3,962        19,937        16,351   

Excess tax benefit from stock-based compensation

     347        851        5,706        1,820   

Change in short-term debt

     (806     834        (1,336     (2,299
  

 

 

   

 

 

   

 

 

   

 

 

 

Total used for financing activities

     (12,644     (27,805     (67,649     (51,128
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate on cash and cash equivalents

     (12,504     12,882        (1,526     (5,369
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     (20,182     (19,965     (61,758     (57,150

Cash and cash equivalents at beginning of period

     231,365        335,529        272,941        372,714   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 211,183      $ 315,564      $ 211,183      $ 315,564   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Includes a $25 million discretionary pension contribution.


CRANE CO.

Order Backlog

(in thousands)

 

     September 30,
2011
    June 30,
2011
    March 31,
2011
    December 31,
2010
    September 30,
2010
 

Aerospace & Electronics

   $ 409,284      $ 431,799      $ 454,559      $ 431,467      $ 401,585   

Engineered Materials

     9,879        13,087        13,826        11,831        11,367   

Merchandising Systems

     20,929  *      26,898  *      25,008  *      30,170  *      18,044   

Fluid Handling

     328,757  **      323,045        305,255        271,825        266,578   

Controls

     32,145        30,323        24,015        22,354        27,575   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Backlog

   $ 800,994      $ 825,152      $ 822,663      $ 767,647      $ 725,149   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

* Includes Order Backlog of $3.8 million at September 30, 2011, $6.2 million at June 30, 2011, $5.3 million at March 31, 2011 and $8.4 million at December 31, 2010 pertaining to the 2010 acquisition of Money Controls.
** Includes Order Backlog of $5.4 million at September 30, 2011 pertaining to the 2011 acquisition of WTA.


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

CASH FLOW ITEMS

        

Cash Provided by (used for) Operating Activities before Asbestos – Related Payments

   $ 73,403      $ 11,566  *    $ 124,227      $ 102,955  * 

Asbestos Related Payments, Net of Insurance Recoveries

     (23,612     (16,167     (59,233     (43,652
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash Provided by (used for) Operating Activities

     49,791        (4,601     64,994        59,303   

Less: Capital Expenditures

     (9,421     (5,199     (27,703     (13,589
  

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 40,370      $ (9,800   $ 37,291      $ 45,714   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Includes a $25 million discretionary pension contribution.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principal payments on the Company’s long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in the context of the definitions of the elements of such measures we provide and in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.